{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:08:29Z","timestamp":1790341709113,"version":"4.1.0"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007109","name":"Universit\u00e0 degli Studi di Ferrara","doi-asserted-by":"publisher","award":["FISR2020IP_04128"],"award-info":[{"award-number":["FISR2020IP_04128"]}],"id":[{"id":"10.13039\/501100007109","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.intimp.2021.108201","type":"journal-article","created":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T02:46:30Z","timestamp":1632797190000},"page":"108201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"PB","title":["In vitro induction of interleukin-8 by SARS-CoV-2 Spike protein is inhibited in bronchial epithelial IB3-1 cells by a miR-93-5p agomiR"],"prefix":"10.1016","volume":"101","author":[{"given":"Jessica","family":"Gasparello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"d'Aversa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Breveglieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Borgatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Finotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Gambari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2021.108201_b0005","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019, novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2021.108201_b0010","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2021.108201_b0015","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0140-6736(20)30185-9","article-title":"A novel coronavirus outbreak of global health concern","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2021.108201_b0020","first-page":"1","article-title":"System dynamics analysis of COVID-19 prevention and control strategies","author":"Jia","year":"2021","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"10.1016\/j.intimp.2021.108201_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.198114","article-title":"COVID-19 Vaccine: A comprehensive status report","volume":"288","author":"Kaur","year":"2020","journal-title":"Virus Res."},{"issue":"2021","key":"10.1016\/j.intimp.2021.108201_b0030","first-page":"1690","article-title":"The 2020 race towards SARS-CoV-2 specific vaccines","volume":"11","author":"Karpi\u0144ski","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.intimp.2021.108201_b0035","doi-asserted-by":"crossref","DOI":"10.4110\/in.2021.21.e5","article-title":"Ongoing clinical trials of vaccines to fight against COVID-19 pandemic","volume":"21","author":"Chakraborty","year":"2021","journal-title":"Immune Netw.."},{"key":"10.1016\/j.intimp.2021.108201_b0040","article-title":"Impact of SARS-CoV-2 variant-associated RBD mutations on the susceptibility to serum antibodies elicited by COVID-19 infection or vaccination","author":"Chen","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.intimp.2021.108201_b0045","first-page":"1","article-title":"A comprehensive review of COVID-19 virology, vaccines, variants, and therapeutics","author":"Forchette","year":"2021","journal-title":"Curr. Med. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2021.108201_b0050","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jgg.2021.03.001","article-title":"The challenge of emerging SARS-CoV-2 mutants to vaccine development","volume":"48","author":"Li","year":"2021","journal-title":"J. Genet. Genomics"},{"key":"10.1016\/j.intimp.2021.108201_b0055","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/joim.13091","article-title":"COVID-19 diagnosis and management: a comprehensive review","volume":"288","author":"Pascarella","year":"2020","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.intimp.2021.108201_b0060","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1126\/scitranslmed.abe4282","article-title":"Lung transplantation for patients with severe COVID-19","volume":"12","author":"Bharat","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.intimp.2021.108201_b0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/JCMA.0000000000000463","article-title":"Clinical Manifestation and Disease Progression in COVID-19 Infection","volume":"84","author":"Tsai","year":"2020","journal-title":"J. Chin. Med. Assoc."},{"key":"10.1016\/j.intimp.2021.108201_b0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0242651","article-title":"Outcomes of mechanically ventilated patients with COVID-19 associated respiratory failure","volume":"15","author":"King","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2021.108201_b0075","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2021.108201_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155151","article-title":"COVID-19 cytokine storm: The anger of inflammation","volume":"133","author":"Mahmudpour","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2021.108201_b0085","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.immuni.2020.04.003","article-title":"COVID-19: A new virus, but a familiar receptor and cytokine release syndrome","volume":"52","author":"Hirano","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2021.108201_b0090","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/infdis\/jiaa363","article-title":"Serum cytokine and chemokine profile in relation to the severity of coronavirus disease 2019 (COVID-19) in China","volume":"222","author":"Chi","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.intimp.2021.108201_b0095","first-page":"30267","article-title":"Therapeutic blockade of granulocyte macrophage colony-stimulating factor in COVID-19-associated hyperinflammation: challenges and opportunities","volume":"S2213-S2600","author":"Mehta","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"5","key":"10.1016\/j.intimp.2021.108201_b0100","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1034\/j.1399-3003.2000.15e14.x","article-title":"G-CSF and IL-8 but not GM-CSF correlate with severity of pulmonary neutrophilia in acute respiratory distress syndrome","volume":"15","author":"Aggarwal","year":"2000","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.intimp.2021.108201_b0105","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s40259-020-00430-1","article-title":"Potential Role of Anti-interleukin (IL)-6 Drugs in the Treatment of COVID-19: Rationale, Clinical Evidence and Risks","volume":"34","author":"Crisafulli","year":"2020","journal-title":"BioDrugs"},{"key":"10.1016\/j.intimp.2021.108201_b0110","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1007\/s10067-020-05190-5","article-title":"Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment","volume":"39","author":"Soy","year":"2020","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.intimp.2021.108201_b0115","article-title":"Deciphering the COVID-19 cytokine storm: Systematic review and meta-analysis","volume":"14","author":"Mulchandani","year":"2020","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.intimp.2021.108201_b0120","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s41232-020-00146-3","article-title":"How COVID-19 induces cytokine storm with high mortality","volume":"40","author":"Hojyo","year":"2020","journal-title":"Inflamm. Regen."},{"key":"10.1016\/j.intimp.2021.108201_b0125","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1002\/ptr.6776","article-title":"Cytokine storm in COVID-19 and parthenolide: preclinical evidence","volume":"34","author":"Bahrami","year":"2020","journal-title":"Phytother. Res."},{"key":"10.1016\/j.intimp.2021.108201_b0130","doi-asserted-by":"crossref","unstructured":"D.M. Del Valle, S. Kim-Schulze, H. Hsin-Hui, N.D. Beckmann, S. Nirenberg, B. Wang, Y. Lavin, T. Swartz, D. Madduri, A. Stock, T. Marron, H. Xie, M.K. Patel, O. van Oekelen, A. Rahman, P. Kovatch, J. Aberg, E. Schadt, S. Jagannath, M. Mazumdar, A. Charney, A. Firpo-Betancourt, D.R. Mendu, J. Jhang, D. Reich, K. Sigel, C. Cordon-Cardo, M. Feldmann, S. Parekh, M. Merad, S. Gnjatic. An inflammatory cytokine signature helps predict COVID-19 severity and death. medRxiv (2020) 10.1101\/2020.05.28.20115758.","DOI":"10.1101\/2020.05.28.20115758"},{"key":"10.1016\/j.intimp.2021.108201_b0135","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1111\/bph.15166","article-title":"M, Ruiz-Ortega, Statins: Could an old friend help the fight against COVID-19?","volume":"177","author":"Rodrigues-Diez","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2021.108201_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104939","article-title":"Review on the potential action mechanisms of Chinese medicines in treating Coronavirus Disease 2019 (COVID-19)","volume":"158","author":"Huang","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.intimp.2021.108201_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104901","article-title":"Anti-malarial drug, artemisinin and its derivatives for the treatment of respiratory diseases","volume":"158","author":"Cheong","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.intimp.2021.108201_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104850","article-title":"Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-\u03baB signaling pathway","volume":"158","author":"Ma","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.intimp.2021.108201_b0155","doi-asserted-by":"crossref","first-page":"E1770","DOI":"10.3390\/jcm9061770","article-title":"Silibinin and SARS-CoV-2: dual targeting of host cytokine storm and virus replication machinery for clinical management of COVID-19 Patients","volume":"9","author":"Bosch-Barrera","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.intimp.2021.108201_b0160","doi-asserted-by":"crossref","unstructured":"C. Pelaia, C. Tinello, A. Vatrella, G. De Sarro, G. Pelaia, Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications, Ther. Adv. Respir. Dis. 14 (2020) 1753466620933508. 10.1177\/1753466620933508.","DOI":"10.1177\/1753466620933508"},{"issue":"6","key":"10.1016\/j.intimp.2021.108201_b0165","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41584-020-0419-z","article-title":"Translating IL-6 biology into effective treatments","volume":"16","author":"Choy","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"issue":"4","key":"10.1016\/j.intimp.2021.108201_b0170","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.bbrc.2007.04.081","article-title":"Induction of IL-6 gene expression in a CF bronchial epithelial cell line by Pseudomonas aeruginosa is dependent on transcription factors belonging to the Sp1 superfamily","volume":"357","author":"Borgatti","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2011","key":"10.1016\/j.intimp.2021.108201_b0175","doi-asserted-by":"crossref","first-page":"6069","DOI":"10.4049\/jimmunol.1100821","article-title":"Mapping the transcriptional machinery of the IL-8 gene in human bronchial epithelial cells","volume":"187","author":"Bezzerri","year":"2011","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2021.108201_b0180","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/path.5095","article-title":"O, Tabary, Small RNA and transcriptome sequencing reveal the role of miR-199a-3p in inflammatory processes in cystic fibrosis airways","volume":"245","author":"Bardin","year":"2018","journal-title":"J. Pathol."},{"issue":"5","key":"10.1016\/j.intimp.2021.108201_b0185","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1183\/09031936.00163414","article-title":"miR-17 overexpression in cystic fibrosis airway epithelial cells decreases interleukin-8 production","volume":"46","author":"Oglesby","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.intimp.2021.108201_b0190","first-page":"11604","article-title":"Elevated miR-155 promotes inflammation in cystic fibrosis by driving hyperexpression of interleukin-8","volume":"286","author":"Bhattacharyya","year":"2011","journal-title":"J. Biol."},{"key":"10.1016\/j.intimp.2021.108201_b0195","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3390\/cells7080092","article-title":"MicroRNAs and Osteoarthritis","volume":"7","author":"Malemud","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2021.108201_b0200","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13072-019-0311-8","article-title":"The role of cigarette smoke-induced epigenetic alterations in inflammation","volume":"12","author":"Zong","year":"2019","journal-title":"Epigenetics Chromatin."},{"key":"10.1016\/j.intimp.2021.108201_b0205","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrg1379","article-title":"MicroRNAs: small RNAs with a big role in gene regulation","volume":"5","author":"He","year":"2004","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.intimp.2021.108201_b0210","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1242\/dev.02073","article-title":"MicroRNA functions in animal development and human disease","volume":"132","author":"Alvarez-Garcia","year":"2005","journal-title":"Development"},{"key":"10.1016\/j.intimp.2021.108201_b0215","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1165\/rcmb.2013-0160OC","article-title":"R, Gambari, Expression of microRNA-93 and Interleukin-8 during Pseudomonas aeruginosa-mediated induction of proinflammatory responses","volume":"50","author":"Fabbri","year":"2014","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"10.1016\/j.intimp.2021.108201_b0220","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/jlb.56.5.559","article-title":"Essential involvement of interleukin-8 (IL-8) in acute inflammation","volume":"56","author":"Harada","year":"1994","journal-title":"J. Leukocyte Biol."},{"key":"10.1016\/j.intimp.2021.108201_b0225","first-page":"vdaa047","article-title":"MicroRNA-93 acts as an \u201canti-inflammatory tumor suppressor\u201d in glioblastoma","volume":"2","author":"H\u00fcbner","year":"2020","journal-title":"Neurooncol. Adv."},{"key":"10.1016\/j.intimp.2021.108201_b0230","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1186\/s12885-015-1659-1","article-title":"Regulation of IL-8 gene expression in gliomas by microRNA miR-93","volume":"15","author":"Fabbri","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.intimp.2021.108201_b0235","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/toxsci\/kfz074","article-title":"Circular RNA 0039411 Is Involved in Neodymium Oxide-induced Inflammation and Antiproliferation in a Human Bronchial Epithelial Cell Line via Sponging miR-93-5p","volume":"17","author":"Hua","year":"2019","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.intimp.2021.108201_b0240","doi-asserted-by":"crossref","unstructured":"P.L. Zeitlin, L. Lu, J.S. Rhim, G. Cutting, G. Stetten, K.A. Kieffer, R. Craig, W.B. Guggino, A cystic fibrosis bronchial epithelial cell line: immortalization by adeno-12-SV40 infection. Am. J. Respir. Cell Mol. Biol. 4 (1991) 313-319. 10.1165\/ajrcmb\/4.4.313.","DOI":"10.1165\/ajrcmb\/4.4.313"},{"key":"10.1016\/j.intimp.2021.108201_b0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2007.02.007","article-title":"Y, She, Up-regulation of IL-6 and TNF-alpha induced by SARS-coronavirus spike protein in murine macrophages via NF-kappaB pathway","volume":"128","author":"Wang","year":"2007","journal-title":"Virus Res."},{"key":"10.1016\/j.intimp.2021.108201_b0250","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.3390\/ijms18122530","article-title":"BCL11A mRNA Targeting by miR-210: A Possible Network Regulating \u03b3-Globin Gene Expression","volume":"18","author":"Gasparello","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2021.108201_b0255","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1089\/nat.2019.0825","article-title":"High Levels of Apoptosis Are Induced in the Human Colon Cancer HT-29 Cell Line by Co-Administration of Sulforaphane and a Peptide Nucleic Acid Targeting miR-15b-5p","volume":"30","author":"Gasparello","year":"2020","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.intimp.2021.108201_b0260","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3892\/ijo.2015.3308","article-title":"High levels of apoptosis are induced in human glioma cell lines by co-administration of peptide nucleic acids targeting miR-221 and miR-222","volume":"48","author":"Brognara","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.intimp.2021.108201_b0265","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.omtn.2019.09.029","article-title":"Efficient Delivery of MicroRNA and AntimiRNA Molecules Using an Argininocalix[4]arene Macrocycle","volume":"18","author":"Gasparello","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"5","key":"10.1016\/j.intimp.2021.108201_b0270","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.tiv.2014.04.012","article-title":"Comparative effects between electronic and cigarette smoke in human keratinocytes and epithelial lung cells","volume":"28","author":"Cervellati","year":"2014","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.intimp.2021.108201_b0275","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12931-020-01445-6","article-title":"SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis","volume":"21","author":"Xu","year":"2020","journal-title":"Respir. Res."},{"issue":"3","key":"10.1016\/j.intimp.2021.108201_b0280","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4062\/biomolther.2020.226","article-title":"Differential Signaling and Virus Production in Calu-3 Cells and Vero Cells upon SARS-CoV-2 Infection","volume":"29","author":"Park","year":"2021","journal-title":"Biomol. Ther. (Seoul)"},{"key":"10.1016\/j.intimp.2021.108201_b0285","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3892\/ijmm.2020.4610","article-title":"MicroRNA-93 contributes to the suppression of lung inflammatory responses in LPS-induced acute lung injury in mice via the TLR4\/MyD88\/NF-kappaB signaling pathway","volume":"46","author":"Gao","year":"2020","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.intimp.2021.108201_b0290","doi-asserted-by":"crossref","DOI":"10.1002\/cbin.11653","article-title":"miRNAs; a novel strategy for the treatment of COVID-19","author":"Ying","year":"2021","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.intimp.2021.108201_b0295","first-page":"1","article-title":"The potential use of microRNAs as a therapeutic strategy for SARS-CoV-2 infection","author":"Hu","year":"2021","journal-title":"Arch. Virol."},{"issue":"2","key":"10.1016\/j.intimp.2021.108201_b0300","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/14787210.2020.1812385","article-title":"COVID-19: fighting the invisible enemy with microRNAs","volume":"19","author":"Chauhan","year":"2021","journal-title":"Expert Rev. Anti. Infect. Ther."},{"key":"10.1016\/j.intimp.2021.108201_b0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.110203","article-title":"A new approach for COVID-19 treatment by micro-RNA","volume":"143","author":"El-Nabi","year":"2020","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.intimp.2021.108201_b0310","first-page":"18","article-title":"miRCOVID-19: Potential Targets of Human miRNAs in SARS-CoV-2 for RNA-Based Drug Discovery","volume":"7","author":"Alam","year":"2021","journal-title":"Noncoding RNA"},{"key":"10.1016\/j.intimp.2021.108201_b0315","doi-asserted-by":"crossref","first-page":"6094","DOI":"10.3390\/ijms22116094","article-title":"In Silico and In Vitro Analyses Validate Human MicroRNAs Targeting the SARS-CoV-2 3'-UTR","volume":"22","author":"Barreda-Manso","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2021.108201_b0320","first-page":"37","article-title":"microRNA Heterogeneity, Innate-Immune Defense and the Efficacy of SARS-CoV-2 Infection-A Commentary","volume":"7","author":"Lukiw","year":"2021","journal-title":"Noncoding RNA"},{"key":"10.1016\/j.intimp.2021.108201_b0325","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3390\/biomedicines8110462","article-title":"miR-98 Regulates TMPRSS2 Expression in Human Endothelial Cells: Key Implications for COVID-19","volume":"8","author":"Matarese","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.intimp.2021.108201_b0330","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.656700","article-title":"SARS-CoV-2 Spike Targets USP33-IRF9 Axis via Exosomal miR-148a to Activate Human Microglia","volume":"12","author":"Mishra","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2021.108201_b0335","first-page":"9","article-title":"miR-24 Targets the Transmembrane Glycoprotein Neuropilin-1 in Human Brain Microvascular Endothelial Cells","volume":"7","author":"Mone","year":"2021","journal-title":"Noncoding RNA"},{"key":"10.1016\/j.intimp.2021.108201_b0340","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.3390\/cells10071762","article-title":"Viral MicroRNAs Encoded by Nucleocapsid Gene of SARS-CoV-2 Are Detected during Infection, and Targeting Metabolic Pathways in Host Cells","volume":"10","author":"Meng","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2021.108201_b0345","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s13054-021-03731-1","article-title":"Role of endothelial miR-24 in COVID-19 cerebrovascular events","volume":"25","author":"Gambardella","year":"2021","journal-title":"Crit. Care"},{"key":"10.1016\/j.intimp.2021.108201_b0350","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.14336\/AD.2021.0223","article-title":"Polyphenols could prevent SARS-CoV-2 infection by modulating the expression of miRNAs in the host cells","volume":"12","author":"Milenkovic","year":"2021","journal-title":"Aging Dis."},{"key":"10.1016\/j.intimp.2021.108201_b0355","article-title":"The interplay between inflammatory pathways and COVID-19: A critical review on pathogenesis and therapeutic options","volume":"150","author":"Choudhary","year":"2020","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.intimp.2021.108201_b0360","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.3390\/nano10112301","article-title":"Biomimetic Nanoparticles Potentiate the Anti-Inflammatory Properties of Dexamethasone and Reduce the Cytokine Storm Syndrome: An Additional Weapon against COVID-19?","volume":"10","author":"Molinaro","year":"2020","journal-title":"Nanomaterials (Basel)"},{"key":"10.1016\/j.intimp.2021.108201_b0365","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.10322","article-title":"The efficacy of IL-6 inhibitor Tocilizumab in reducing severe COVID-19 mortality: a systematic review","volume":"8","author":"Kaye","year":"2020","journal-title":"PeerJ."},{"key":"10.1016\/j.intimp.2021.108201_b0370","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s10020-020-00230-x","article-title":"IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19","volume":"26","author":"Chen","year":"2020","journal-title":"Mol. Med."},{"issue":"2","key":"10.1016\/j.intimp.2021.108201_b0375","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1039\/D0LC00678E","article-title":"A digital protein microarray for COVID-19 cytokine storm monitoring","volume":"21","author":"Song","year":"2021","journal-title":"Lab Chip."},{"key":"10.1016\/j.intimp.2021.108201_b0380","first-page":"282","article-title":"Increased inflammatory markers correlate with liver damage and predict severe COVID-19: a systematic review and meta-analysis","volume":"13","author":"Amiri-Dashatan","year":"2020","journal-title":"Gastroenterol. Hepatol. Bed Bench"},{"key":"10.1016\/j.intimp.2021.108201_b0385","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s12890-020-01343-z","article-title":"Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome","volume":"20","author":"Pandolfi","year":"2020","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.intimp.2021.108201_b0390","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/s41419-020-03151-z","article-title":"Age-severity matched cytokine profiling reveals specific signatures in Covid-19 patients","volume":"11","author":"Angioni","year":"2020","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.intimp.2021.108201_b0395","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s12026-020-09156-2","article-title":"Immune characteristics distinguish patients with severe disease associated with SARS-CoV-2","volume":"68","author":"Li","year":"2020","journal-title":"Immunol. Res."},{"key":"10.1016\/j.intimp.2021.108201_b0400","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12931-020-01511-z","article-title":"REACT COVID investigators, Inflammatory phenotyping predicts clinical outcome in COVID-19","volume":"21","author":"Burke","year":"2020","journal-title":"Respir. Res."},{"key":"10.1016\/j.intimp.2021.108201_b0405","article-title":"Cytokine profile and disease severity in patients with COVID-19","volume":"137","author":"Ghazavi","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2021.108201_b0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155190","article-title":"Cytokine prediction of mortality in COVID19 patients","volume":"134","author":"Mandel","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2021.108201_b0415","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1080\/1744666X.2021.1847084","article-title":"Coronavirus disease 2019, investigational therapies in the prevention and treatment of hyperinflammation","volume":"16","author":"Amigues","year":"2020","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.intimp.2021.108201_b0420","first-page":"1","article-title":"Unique immunological profile in patients with COVID-19, Cell","author":"Varchetta","year":"2020","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.intimp.2021.108201_b0425","article-title":"Small molecule therapeutics for COVID-19: repurposing of inhaled furosemide","volume":"8","author":"Wang","year":"2020","journal-title":"PeerJ"},{"issue":"6","key":"10.1016\/j.intimp.2021.108201_b0430","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1164\/rccm.202005-1583OC","article-title":"Characterization of the Inflammatory Response to Severe COVID-19 Illness","volume":"202","author":"McElvaney","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.intimp.2021.108201_b0435","first-page":"1","article-title":"A precision medicine approach to SARS-CoV-2 pandemic management","author":"Crisci","year":"2020","journal-title":"Curr. Treat. Options Allergy."},{"key":"10.1016\/j.intimp.2021.108201_b0440","unstructured":"Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04347226 (2020)."},{"key":"10.1016\/j.intimp.2021.108201_b0445","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s40425-019-0706-x","article-title":"Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors","volume":"7","author":"Bilusic","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.intimp.2021.108201_b0450","doi-asserted-by":"crossref","first-page":"8874339","DOI":"10.1155\/2021\/8874339","article-title":"COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation","author":"Aboudounya","year":"2021","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.intimp.2021.108201_b0455","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/14728222.2021.1918103","article-title":"TLR4 as a therapeutic target for respiratory and neurological complications of SARS-CoV-2","volume":"25","author":"Kaushik","year":"2021","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.intimp.2021.108201_b0460","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.598444","article-title":"NF-\u03baB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients","volume":"11","author":"Kircheis","year":"2020","journal-title":"Front. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921008377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921008377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:33:57Z","timestamp":1761586437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921008377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":92,"alternative-id":["S1567576921008377"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.108201","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro induction of interleukin-8 by SARS-CoV-2 Spike protein is inhibited in bronchial epithelial IB3-1 cells by a miR-93-5p agomiR","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.108201","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108201"}}